glp-1 news today november 2025 As Drugs Go Mainstream, This Expert Says Health is More than a Number on a Scale GLP-1 Receptor Agonist Market Growth

Although much has improved since the first generation came on the market in 2005, pharmaceutical companies are investing significant resources to address four main obstacles: GLP-1 drugs significantly alter consumer behavior

Most long-term studies show that sustained weight loss is associated with improved mental health outcomes, including reduced anxiety

Teva has priced the generic at $1,165 per month, slightly below the $1,350 cost of Saxenda

Includes doctor messaging, free follow-ups, video guides, and access to our peer community

Financial support This research received no specific grant from any funding agency, commercial, or not-for-profit sectors

State-licensed 503A pharmacies can compound semaglutide for patient-specific prescriptions with documented clinical justification, such as an inactive-ingredient allergy or a dose not commercially available